216 related articles for article (PubMed ID: 25268744)
1. Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved.
Vizioli MG; Santos J; Pilotti S; Mazzoni M; Anania MC; Miranda C; Pagliardini S; Pierotti MA; Gil J; Greco A
Oncotarget; 2014 Sep; 5(18):8270-83. PubMed ID: 25268744
[TBL] [Abstract][Full Text] [Related]
2. Escape from p21-mediated oncogene-induced senescence leads to cell dedifferentiation and dependence on anti-apoptotic Bcl-xL and MCL1 proteins.
de Carné Trécesson S; Guillemin Y; Bélanger A; Bernard AC; Preisser L; Ravon E; Gamelin E; Juin P; Barré B; Coqueret O
J Biol Chem; 2011 Apr; 286(15):12825-38. PubMed ID: 21292770
[TBL] [Abstract][Full Text] [Related]
3. Depletion of ERK2 but not ERK1 abrogates oncogenic Ras-induced senescence.
Shin J; Yang J; Lee JC; Baek KH
Cell Signal; 2013 Dec; 25(12):2540-7. PubMed ID: 23993963
[TBL] [Abstract][Full Text] [Related]
4. Induction of cellular senescence by oncogenic RAS.
Gupta R; Wajapeyee N
Methods Mol Biol; 2013; 1048():127-33. PubMed ID: 23929102
[TBL] [Abstract][Full Text] [Related]
5. MYC and RAS are unable to cooperate in overcoming cellular senescence and apoptosis in normal human fibroblasts.
Zhang F; Zakaria SM; Högqvist Tabor V; Singh M; Tronnersjö S; Goodwin J; Selivanova G; Bartek J; Castell A; Larsson LG
Cell Cycle; 2018; 17(24):2697-2715. PubMed ID: 30526305
[TBL] [Abstract][Full Text] [Related]
6. The relative contributions of the p53 and pRb pathways in oncogene-induced melanocyte senescence.
Haferkamp S; Tran SL; Becker TM; Scurr LL; Kefford RF; Rizos H
Aging (Albany NY); 2009 May; 1(6):542-56. PubMed ID: 20157537
[TBL] [Abstract][Full Text] [Related]
7. Detection of Oncogene-Induced Senescence In Vivo.
Baek KH; Ryeom S
Methods Mol Biol; 2017; 1534():185-198. PubMed ID: 27812880
[TBL] [Abstract][Full Text] [Related]
8. Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.
Pantoja C; Serrano M
Oncogene; 1999 Sep; 18(35):4974-82. PubMed ID: 10490832
[TBL] [Abstract][Full Text] [Related]
9. Senescence-Like Phenotypes in Human Nevi.
Joselow A; Lynn D; Terzian T; Box NF
Methods Mol Biol; 2017; 1534():175-184. PubMed ID: 27812879
[TBL] [Abstract][Full Text] [Related]
10. Chronic NF-kappaB activation delays RasV12-induced premature senescence of human fibroblasts by suppressing the DNA damage checkpoint response.
Batsi C; Markopoulou S; Vartholomatos G; Georgiou I; Kanavaros P; Gorgoulis VG; Marcu KB; Kolettas E
Mech Ageing Dev; 2009 Jul; 130(7):409-19. PubMed ID: 19406145
[TBL] [Abstract][Full Text] [Related]
11. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH
Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011
[TBL] [Abstract][Full Text] [Related]
12. p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase.
Zemskova M; Lilly MB; Lin YW; Song JH; Kraft AS
Mol Cancer Res; 2010 Aug; 8(8):1126-41. PubMed ID: 20647331
[TBL] [Abstract][Full Text] [Related]
13. Chemokine signaling via the CXCR2 receptor reinforces senescence.
Acosta JC; O'Loghlen A; Banito A; Guijarro MV; Augert A; Raguz S; Fumagalli M; Da Costa M; Brown C; Popov N; Takatsu Y; Melamed J; d'Adda di Fagagna F; Bernard D; Hernando E; Gil J
Cell; 2008 Jun; 133(6):1006-18. PubMed ID: 18555777
[TBL] [Abstract][Full Text] [Related]
14. A high-content screening assay for small-molecule modulators of oncogene-induced senescence.
Bitler BG; Fink LS; Wei Z; Peterson JR; Zhang R
J Biomol Screen; 2013 Oct; 18(9):1054-61. PubMed ID: 23733845
[TBL] [Abstract][Full Text] [Related]
15. ROS-generating oxidases Nox1 and Nox4 contribute to oncogenic Ras-induced premature senescence.
Kodama R; Kato M; Furuta S; Ueno S; Zhang Y; Matsuno K; Yabe-Nishimura C; Tanaka E; Kamata T
Genes Cells; 2013 Jan; 18(1):32-41. PubMed ID: 23216904
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
17. Senescence of human fibroblasts induced by oncogenic Raf.
Zhu J; Woods D; McMahon M; Bishop JM
Genes Dev; 1998 Oct; 12(19):2997-3007. PubMed ID: 9765202
[TBL] [Abstract][Full Text] [Related]
18. IGFBP-rP1 induces p21 expression through a p53-independent pathway, leading to cellular senescence of MCF-7 breast cancer cells.
Zuo S; Liu C; Wang J; Wang F; Xu W; Cui S; Yuan L; Chen X; Fan W; Cui M; Song G
J Cancer Res Clin Oncol; 2012 Jun; 138(6):1045-55. PubMed ID: 22392074
[TBL] [Abstract][Full Text] [Related]
19. AP4 directly downregulates p16 and p21 to suppress senescence and mediate transformation.
Jackstadt R; Jung P; Hermeking H
Cell Death Dis; 2013 Aug; 4(8):e775. PubMed ID: 23949224
[TBL] [Abstract][Full Text] [Related]
20. Single-cell analysis of p16(INK4a) and p21(WAF1) expression suggests distinct mechanisms of senescence in normal human and Li-Fraumeni Syndrome fibroblasts.
Mirzayans R; Andrais B; Scott A; Paterson MC; Murray D
J Cell Physiol; 2010 Apr; 223(1):57-67. PubMed ID: 20039273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]